-
cbl235689 became a registered member 6 days ago
-
Sherwin Brown became a registered member 6 days ago
-
Smith became a registered member 6 days ago
-
Caroline became a registered member a week ago
-
bestcryptoexchangeforindia posted an update a week ago
Best Crypto Exchange for India – Delta Exchange is a leading cryptocurrency derivatives trading platform offering futures and options on Bitcoin, Ethereum, and other digital assets. Designed for Indian traders, it provides INR deposits, advanced trading tools, deep liquidity, and strong security. With competitive fees and a user-friendly… Read more
-
bestcryptoexchangeforindia became a registered member a week ago
-
nextjsboilerplate posted an update 2 weeks ago
A next js boilerplate is an essential foundation for developers and startups aiming to build scalable, high-performance web applications faster. It comes preconfigured with modern tools like authentication, database integration, payment handling, SEO optimization, and responsive UI components, reducing weeks of development time. By using… Read more
-
nextjsboilerplate became a registered member 2 weeks ago
-
aihomedesignfree posted an update 2 weeks ago
Looking for an ai home design free solution that helps you visualize interiors effortlessly? Modern AI-powered home design platforms allow users to transform empty rooms or existing spaces into beautifully styled interiors within seconds. By using advanced image recognition and smart layout algorithms, these tools generate realistic room… Read more
-
aihomedesignfree became a registered member 2 weeks ago
-
akshay posted an update in the group
3 months agoPharma News 3 months agoPharmaceutical Companies Expand AI Use to Accelerate Drug Discovery
Major pharmaceutical companies are increasingly adopting artificial intelligence to speed up drug discovery and reduce research costs. Industry leaders report that AI-driven platforms are helping identify potential drug candidates faster, optimize clinical trial design, and…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoGlobal Pharma Industry Eyes Faster Patient Access with EU Regulatory Overhaul
The European Union has reached a landmark agreement to reform drug regulations, aiming to speed up patient access to medicines across the bloc. The new framework revises data and market exclusivity rules, supports antibiotic innovation, and strengthens supply…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoNew Cancer Drug License — Hope for Patients in India
As a practising doctor in India, I’m encouraged by the latest development: Dr Reddy’s Laboratories has signed an exclusive licensing agreement with Australia-based Immutep to market a promising new cancer drug — a move that could expand therapeutic options for patients across the…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoIndia’s First Home-grown Antibiotic Is Here
As a doctor, I’m genuinely excited about a recent milestone in Indian medicine — the launch of Nafithromycin, the first antibiotic discovered, developed and clinically validated entirely in India.
This antibiotic — marketed as Miqnaf — promises a short, once-daily, three-day treatment for…
-
neha posted an update in the group
3 months agoPharma News 3 months agoIndian Firm’s Novel Antibiotic ‘Zaynich’ Gets FDA Nod for Review — A Big Step Against Drug-Resistant Infections
The United States Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Zaynich, a first-in-class antibiotic developed by Wockhardt Ltd., marking a historic milestone — it’s the first time an Indian…
-
neha posted an update in the group
3 months agoPharma News 3 months agoFDA Clears New Gene Therapy for Spinal Muscular Atrophy — Big Hope for Older Children & Adults
A groundbreaking approval: the U.S. FDA has cleared Itvisma, a one-time gene therapy for patients aged 2 years and older with Spinal Muscular Atrophy (SMA), offering a potential lifeline for those previously beyond the reach of existing treatments.
-
akshay posted an update in the group
3 months agoPharma News 3 months agoFDA Approves Novel Drug for Rare Fat-Metabolism Disorder
This week, the U.S. Food and Drug Administration (FDA) approved Plozasiran (brand name: Redemplo) — a new siRNA therapy for Familial Chylomicronemia Syndrome (FCS), a rare genetic disorder that causes dangerously high triglyceride levels.
✅ What This Means from a Doctor’s Perspective
-
For…
-
-
neha posted an update in the group
3 months agoPharma News 3 months ago🌟 India’s Home‑grown Antibiotic Breakthrough: A New Hope Against Drug‑Resistant Infections
As a practising physician in India, I’m thrilled by the recent announcement of Nafithromycin — the first antibiotic discovered and developed entirely within India.
For many of us on the front lines, antimicrobial resistance is a growing nightmare: rising…
-
akshay posted an update in the group
3 months agoPharma News 3 months ago🩺 A Doctor’s Note on India’s Pharma Trade Scrutiny
I’m deeply concerned—but also cautiously hopeful—about the recent anti‑dumping probe India has launched into imports of Ethambutol Hydrochloride, a key API used in TB drugs.
From a medical standpoint:
-
Access to TB medicines is non-negotiable—we rely on affordable, consistent supply to treat…
-
-
neha posted an update in the group
4 months agoPharma News 4 months agoIndian Regulators Crack Down: Strict GMP Compliance Required by Year End
As a clinician, the latest move from drug regulators raises both concern and hope. The DCGI has issued a final directive: all pharma manufacturing plants must fully comply with updated Good Manufacturing Practice (GMP) rules by 31 December 2025, or face closure.
Why…
- Load More
